Mylan N.V.

(MYL) Trade

By |

Profile

Mylan NV is a generic pharmaceutical manufacturer which develops, licenses, manufactures, markets and distributes generic, over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories.

Contact Information

Website: www.mylan.com
Email: InvestorRelations@mylan.com
Main Phone: +44 1707853000
Address: Building 4, Trident Place
Address 2: Mosquito Way
State: Herts
City / Town: Hatfield
Country: GBR
Postal Code: AL10 9UL

Issuer Information

Exchange: NGS
CEO: Heather Bresch
Employees: 33417
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 38.11 $ -0.08 (-0.21%)
Last Price 38.11 Change $ -0.08 Change % -0.21 Tick N/A
Bid 38.11 Bid Size 400.00 Ask 38.12 Ask Size 500.00
Open 38.19 High 38.41 Low 37.86 Prev Close 38.19
Last Trade Volume 562,413 52 Wk Hi 47.82 52 Wk Low 30.73
Market Cap 19.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 515,567,254.00 EPS (TTM) 0.86 PE Ratio 44.40 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 76
Number of Buys 0 37
Number of Sells 0 39
Net Activity 0 -182124
Last 10 Buys Shares
Joseph C. Maroon 1,000
Joseph C. Maroon 1,000
Robert Cindrich 1,000
Melina E. Higgins 1,000
Melina E. Higgins 1,000
Melina E. Higgins 1,000
Joseph C. Maroon 1,000
Mark W. Parrish 1,000
Wendy Cameron 1,000
Robert Cindrich 1,000
Last 10 Sell Shares
Paul B. Campbell 1,000
Robert J. Coury 1,000
Anthony Mauro 1,000
Rajiv Malik 1,000
Robert J. Coury 1,000
Heather Bresch 1,000
Heather Bresch 1,000
Rajiv Malik 1,000
Anthony Mauro 1,000
Heather Bresch 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 59 59 59 59
Low Target Price Estimate 36 36 36 37
Mean Target Price Estimate 48.07 48.2 48.27 48.2
Standard Deviation 7.29 7.17 7.12 7.07
Date of Most Recent Estimate 06/01/18 05/29/18 05/22/18 06/06/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 9 10 10 9
Moderate Buy 1 1 1 1
Hold 6 6 6 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.78 1.74 1.74 1.85